Source: ForexYard UK, Euro-Zone Interest Rate Decisions Set to Impact Markets
The EUR/USD spent much of yesterday range trading, as investors were fearful of opening fresh buy positions ahead of possible Greek news. The market place is not forecasted to be nearly as quiet today, as euro-zone and British interest rate decisions and press conferences are forecasted to generate significant volatility. Should any of the news turn out to be negative, investors are likely to revert back to safe-haven assets which could cause the euro and GBP to drop.

The Gold Report: Recent headlines continue to focus on the debt crisis in Europe as more countries are having their debt downgraded. Greg, you have diagnosed the problem as credit addiction and said that the European Union won’t be able to recover until leaders take painful measures necessary to kick their addiction. What does this mean for commodities and commodity equities?
Greg Weldon: It’s critical for asset prices across the globe. It is a debt addiction, debt refinancing and deficit financing problem, not only in Europe, but also in the U.S. and Japan.

Last summer, when Netflix (Nasdaq: NFLX) was messing with its pricing plans, alienating its customers in the process, I spotted a clear opening for rival Coinstar (Nasdaq: CSTR), which runs a kiosk-based DVD distribution system.
As I wrote then: "Thanks to Netflix, Coinstar's DVD business will thrive for even longer than some short sellers had predicted. This is because it's increasingly apparent that Redbox looks set to take some market share.

In four years, the annual event went from 350 to 1,500 attendees with 858 companies participating, including 76 public companies, according to Sara Jane Demy, president of Demy-Colton Life Science Advisors and conference co-founder. The conference, which ran Jan. 9–11, gave small-cap and private biotech companies and investors a focused home during the busy J.P. Morgan Healthcare Conference. “This industry attracts really smart people who are trying to find ways to cure disease and, along the way, earn money for their investors.

The Life Sciences Report: Geoff, what is your current theme?
Geoff Meacham: We were very bullish on the biotech group in 2010 and 2011. Fundamentals are still very good, but I would say we’re more cautious on the performance of the group for all of 2012. One of the things we pointed out in our 2012 Global Biotech Outlook is that the tone of the group before 2012, literally last fall, was very negative. We offered a couple of ideas of what could change the sentiment very positively. It turns out that a lot of that stuff actually happened.

Source: ForexYard EU Debt Crisis Continues to Fuel Risk Aversion
The euro-zone debt crisis continued to fuel risk aversion in the market place yesterday, as poor news briefly brought the EUR/USD pair below the 1.3100 level. The pair staged a recovery later in the European session, after it was revealed that Greek leaders had begun finalizing a debt swap deal. Today, traders will want to continue monitoring the euro-zone situation, especially as it is becoming clear that Portugal will soon need a bailout to avoid defaulting on its debt.

The Energy Report: Yves, what can investors expect out of MLPs between now and the end of 2013?
Yves Siegel: Steady as she goes. The yields for our group now are around 6%, and we expect distribution growth to be about 7%. If Fed Chairman Ben Bernanke is true to his word, we’ll continue to expect an environment of low interest rates for the next two years. So if you combine the yield and the distribution growth, we think investors could see low double-digit returns.
TER: How do distributions grow?

Many investors have rejected emerging markets, and I can't say I blame them. As a group, emerging markets really went sour in 2011, dropping nearly 19% and trailing the S&P 500's 2% gain by about 21%. Still, I urge those who feel these markets are nothing but bad news to reconsider. After returning 76% in 2009 and 19% in 2010, they were due for a pullback. But now, emerging markets have resumed their upward march, rising more than 14% so far this year, compared with about a 6% gain for the S&P 500.

BlackRock rolled out seven new single-country ETFs in late January.  Three are the first iShares products to individually target Denmark, Finland, and Norway.  Four others complement existing large cap offerings with small-cap exposure in Australia, Canada, Germany, and the U.K.
January was a busy month for BlackRock, which rolled out a dozen new iShares-branded international ETFs in the month.  Even more interesting, the listings were done on three different U.S. stock exchanges.

Last year, I made a prediction that Mark Zuckerberg would eventually become the world’s richest man, or at least come very close to it. The past week has been heaven for those who like me have been greatly anticipating the upcoming Facebook IPO. As Facebook finally filed for its IPO, Zuckerberg confirmed what many including myself firmly believed; that he plans on leading Facebook to the very top.